They identified esophageal cancer as one of those obesity-related cancers and found a significantly lower risk of esophageal cancer in patients on GLP-1 RAs (HR, 0.60; 95% CI, 0.42–0.86) compared to ours (HR, 0.34; 95% CI, 0.26–0.45). This evidence concerns the gene GLP1R and esophageal cancer.